(Q53150829)
Statements
Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. (English)
Jane McKenzie
Renée de Mutsert
Raymond Azar
Daniel Teta
Mathias Plauth
Noel Cano
Renilon Multicentre Trial Study Group
11 April 2008
23
9
2902-2910